NASDAQ · STOCK
Charles River Laboratories
$232.67
52W $144.26 – $242.73
52/100
$11.20B
-62.0
1.40
Is CRL Bullish or Bearish?
Mixed.
Innellis AI committee rates Charles River Laboratories (CRL) Watch with a composite score of 52/100
, based on 6 analysts with 100% agreement.
Last updated July 31, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +7.55 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -12.45 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee sees neither a compelling opportunity nor a clear risk at this stage. Conditions remain neutral — patience is warranted.
Bull & Bear Case
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
- Market regime is bullish (Bull market -- normal position sizing) — Macro
- Beta of 1.37 means this name should amplify a favorable market regime — Macro
Bear Case
- ROE of only -5.7% -- cheap may mean cheap for a reason — Value
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of July 31, 2026
Overall Committee Score
52/100
Agreement
100%
Analysts
6
Conviction
Unanimous
Sector Rank
Top 72%
of 93 Healthcare peers
Value Analyst
neutral
42
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
− ROE of only -5.7% -- cheap may mean cheap for a reason
Growth Analyst
neutral
52
/ 100 · High confidence
Moderate growth -- present but not remarkable
+ 4 consecutive earnings beats -- consistent execution
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Macro Analyst
neutral
58
/ 100 · Moderate confidence
Macro backdrop is mixed or neutral -- not a strong tailwind or headwind either way
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
neutral
60
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2744.14)
Investment Thesis Evolution
Committee score moved marginally from 53.7 to 52.5.
- Conviction changed from high to unanimous.
- Committee agreement increased notably from 83% to 100%.
- New bearish signals: 2 appeared.
- New bullish signals: 2 appeared.
- Bearish pressure eased: 2 signal(s) disappeared.
- Analyst(s) changed stance: Macro Analyst.
Analyst-level changes:
- Macro Analyst: stance bullish->neutral; score 65->58 (-8); +2 bullish signal(s).
- Portfolio Manager: +2 bearish signal(s).
Comparing 2026-07-30 to 2026-07-31 (1 day apart).
Technical Analysis
RSI (14)
57.0
Neutral
MACD Histogram
-0.757
Bearish Momentum
Trend Direction
Uptrend
Weekly: Sideways
Market Structure
Hh Hl
Support
$221.07
Resistance
$239.73
Bollinger %B
0.67
Inside Bands
Price vs Moving Averages
EMA 9
$230.85
Above
EMA 21
$225.21
Above
EMA 50
$210.36
Above
EMA 200
$187.78
Above
Fundamental Analysis
Valuation
88
Growth
57
Profitability
0
Financial Health
60
Cash Flow
37
Valuation
P/E Ratio
-62.0×
P/B Ratio
3.87×
PEG Ratio
0.62
Dividend Yield
0.00%
52W High
$242.73
52W Low
$144.26
Quality & Growth
ROE
-4.6%
ROA
-2.0%
Gross Margin
31.9%
Operating Margin
11.8%
Revenue Growth YoY
—
Debt / Equity
1.04
AI Fundamental Assessment
P/E ratio of -62.0 (inexpensive relative to a 15-40x range); Price-to-book of 3.9x; PEG ratio of 0.6 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -0.0%; Return on assets of -0.0%; Net margin of -0.0%; Gross margin of 0.3%; Current ratio of 1.36 (tight short-term liquidity); Debt-to-equity of 1.04; Free cash flow margin of 0.6% (thin cash generation); Free cash flow per share is positive (7.99); Most recent quarter beat estimates by 5.0%; 4 consecutive earnings beats; EPS growth decelerating (-1.6% -> -13.8% QoQ); Analyst estimates falling over recent quarters
Get the Full CRL Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →